港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

英派藥業-B

13.020

+0.0700.54%

成交量：617.86萬

成交額：8,436.49萬

市值：36.78億

市盈率：-10.06

高：14.500

開：13.290

低：12.820

收：12.950

52周最高：47.980

52周最低：10.310

股本：2.82億

香港流通股本：2.82億

量比：2.25

換手率：2.19%

股息：- -

股息率：- -

每股收益(LYR):-1.295

淨資產收益率：--

總資產收益率：-40.35%

市淨率：4.04

市盈率(LYR):-10.06

市銷率: 26.49

資料載入中...

總覽公司新聞資訊公告

異動解讀｜英派藥業-B盤中上漲9.03%，塞納帕利獲CHMP積極意見持續催化

英派藥業－Ｂ(07630)股價顯著上升11.042%，現價港幣$14.38

阿斯达克财经

英派藥業－Ｂ(07630)股價顯著上升11.156%，現價港幣$13.65

阿斯达克财经

異動解讀｜英派藥業-B盤中下跌8.07%，塞納帕利獲批利好兑現後資金獲利了結

英派藥業－Ｂ(07630)股價下跌8.075%，現價港幣$13.32

阿斯达克财经

英派藥業-B9月股份變動月報：股本維持不變

異動解讀｜英派藥業-B盤中上漲8.26%，塞納帕利歐洲CHMP獲批利好持續發酵

英派藥業－Ｂ(07630)股價上升5.093%，現價港幣$13.62

阿斯达克财经

異動解讀｜英派藥業-B盤中下跌8.05%，前期大漲後回調疊加生物科技板塊整體走弱

英派藥業－Ｂ(07630)出現大手賣出70.72萬股，成交價$14.53，涉資1.028千萬

阿斯达克财经

港股收盤(09.21) | 恒指漲1.18%重上兩萬五創新藥概念股全線爆發中生製藥(01177)領升藍籌

英派藥業－Ｂ(07630)股價大幅上升47.352%，現價港幣$19.2

阿斯达克财经

英派藥業-B（07630）盤中拉升逾40% 藥品Sepalna上市許可獲歐洲CHMP建議批准

港股異動 | 英派藥業-B(07630.HK)漲幅擴大逾41% 塞納帕利國際化里程碑落地公司入通有望持續吸引南下資金

英派藥業-B盤初大漲逾22%，塞納帕利獲CHMP積極意見

港股異動 | 英派藥業-B(07630.HK)高開逾7% 塞納帕利獲CHMP積極意見近期與Pharmanovia達成獨家合作

智通港股早知道 | 住建部指房地產進入存量時代 MiniMax(00100) Code CLI正式開源

重磅利好落地！塞納帕利獲歐洲藥品管理局批准英派藥業-B (07630)收盤大漲15.51%

英派藥業-B(07630.HK)：塞納帕利獲CHMP積極意見有望用於晚期上皮性卵巢癌、輸卵管癌及原發性腹膜癌的一線維持治療

英派藥業-B（07630）PARP抑制劑塞納帕利獲EMA CHMP積極意見邁向歐盟上市關鍵一步

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/07630/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"英派藥業-B","latestPrice":13.02,"timestamp":1792138094538,"preClose":12.95,"halted":0,"volume":6178600,"delay":0,"changeRate":0.005405405405405427,"floatShares":282461530,"shares":282461530,"eps":-1.294715,"marketStatus":"重陽節翌日休市","change":0.07,"latestTime":"10-16 16:08:14","open":13.29,"high":14.5,"low":12.82,"amount":84364938,"amplitude":0.12973,"askPrice":13.02,"askSize":3400,"bidPrice":12.97,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.052,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":12.95,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":2.2529243603096694,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.294715,"volumeRatio":2.2529243603096694,"shares":282461530,"dividePrice":0,"high":14.5,"amplitude":0.12973,"preClose":12.95,"low":12.82,"week52Low":10.31,"pbRate":"4.04","psRate":"26.49","week52High":47.98,"institutionHeld":0,"latestPrice":13.02,"committee":-0.888889,"eps":-1.294715,"divideRate":0,"volume":6178600,"delay":0,"ttmEps":-1.052,"open":13.29,"prevYearClose":20.1,"prevWeekClose":13.02,"prevMonthClose":14.07,"prevQuarterClose":14.07,"fiveDayClose":12.68,"twentyDayClose":11.28,"sixtyDayClose":12.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"07630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1782403200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-10-15","current":-12.376426,"percent":0.607477,"low":-34.323153,"twenty":-29.852178,"median":-13.23402,"eighty":-10.652923,"high":-8.821219,"avg":-17.72259,"sd":8.718874,"marketCap":3657876813},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-12","current":-29.369689,"twenty":-32.33377,"median":-30.548005,"eighty":-29.705347,"marketCap":10052410732},{"date":"2026-06-18","current":-29.78235,"twenty":-32.303072,"median":-30.338658,"eighty":-29.742668,"marketCap":10218109810},{"date":"2026-06-26","current":-29.297581,"twenty":-32.241427,"median":-30.11999,"eighty":-29.607619,"marketCap":10002701008},{"date":"2026-07-03","current":-16.26247,"twenty":-32.218614,"median":-29.994357,"eighty":-29.297581,"marketCap":5556442415},{"date":"2026-07-10","current":-15.780707,"twenty":-31.493905,"median":-29.916258,"eighty":-25.475578,"marketCap":5385220035},{"date":"2026-07-17","current":-11.297625,"twenty":-31.022068,"median":-29.816044,"eighty":-15.922995,"marketCap":3869073471},{"date":"2026-07-24","current":-9.271485,"twenty":-30.958502,"median":-29.609087,"eighty":-15.602668,"marketCap":3175898995},{"date":"2026-07-31","current":-10.646015,"twenty":-30.630104,"median":-29.369689,"eighty":-13.307417,"marketCap":3653664669},{"date":"2026-08-07","current":-10.047131,"twenty":-30.493855,"median":-29.24895,"eighty":-10.58915,"marketCap":3454825776},{"date":"2026-08-14","current":-10.299125,"twenty":-30.36699,"median":-25.475578,"eighty":-10.316459,"marketCap":3545960269},{"date":"2026-08-21","current":-10.772628,"twenty":-30.33128,"median":-16.418396,"eighty":-10.292557,"marketCap":3717182649},{"date":"2026-08-28","current":-12.490535,"twenty":-30.224959,"median":-15.896725,"eighty":-10.316459,"marketCap":4310937679},{"date":"2026-09-04","current":-14.62831,"twenty":-30.072679,"median":-15.691688,"eighty":-10.353511,"marketCap":4403575252},{"date":"2026-09-11","current":-12.087934,"twenty":-30.026033,"median":-14.57977,"eighty":-10.495083,"marketCap":3643753737},{"date":"2026-09-18","current":-12.193817,"twenty":-29.977617,"median":-13.665771,"eighty":-10.535977,"marketCap":3680473735},{"date":"2026-09-25","current":-12.65778,"twenty":-29.936332,"median":-13.862539,"eighty":-10.54718,"marketCap":3813230655},{"date":"2026-10-02","current":-13.309453,"twenty":-29.921275,"median":-13.342238,"eighty":-10.553476,"marketCap":4013778341},{"date":"2026-10-09","current":-11.861614,"twenty":-29.878786,"median":-13.325845,"eighty":-10.610057,"marketCap":3581612200},{"date":"2026-10-15","current":-12.092826,"twenty":-29.852178,"median":-13.23402,"eighty":-10.652923,"marketCap":3657876813}],"updateTime":1792414779390},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1181360178","title":"異動解讀｜英派藥業-B盤中上漲9.03%，塞納帕利獲CHMP積極意見持續催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1181360178","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181360178?lang=zh_tw&edition=fundamental","pubTime":"2026-10-16 11:48","pubTimestamp":1792122536,"startTime":"0","endTime":"0","summary":"10月16日，英派药业-B盘中上涨9.03%，报14.12港元，成交额3870.87万港元。消息面上，公司核心产品塞纳帕利此前获得欧洲药品管理局人用药品委员会积极意见，建议批准其用于晚期上皮性卵巢癌、输卵管癌及原发性腹膜癌的一线维持治疗，后续将提交欧盟委员会作最终决定。此外，公司9月已纳入沪深港通，叠加上半年收入1.05亿元、同比增长316.8%，核心产品商业化与国际化进展共同支撑市场情绪。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"塞纳帕利获CHMP积极意见，英派药业盘中上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675568634","title":"英派藥業－Ｂ(07630)股價顯著上升11.042%，現價港幣$14.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2675568634","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675568634?lang=zh_tw&edition=fundamental","pubTime":"2026-10-16 11:48","pubTimestamp":1792122480,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在上午11:48比前收市价显著上升11.042%，现股价为港币$14.38。至目前为止，今日最高价为$14.38，而最低价为$12.82。总成交量为292.32万股，总成交金额为港币$3.968千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144023737_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144023737_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610162581/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610162581/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675536397","title":"英派藥業－Ｂ(07630)股價顯著上升11.156%，現價港幣$13.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2675536397","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675536397?lang=zh_tw&edition=fundamental","pubTime":"2026-10-14 11:31","pubTimestamp":1791948660,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在上午11:31比前收市价显著上升11.156%，现股价为港币$13.65。至目前为止，今日最高价为$13.65，而最低价为$12.38。总成交量为184万股，总成交金额为港币$2.365千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144025903_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144025903_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610142217/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610142217/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105965472","title":"異動解讀｜英派藥業-B盤中下跌8.07%，塞納帕利獲批利好兑現後資金獲利了結","url":"https://stock-news.laohu8.com/highlight/detail?id=1105965472","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105965472?lang=zh_tw&edition=fundamental","pubTime":"2026-10-08 14:05","pubTimestamp":1791439539,"startTime":"0","endTime":"0","summary":"10月8日，英派药业-B盘中下跌8.07%，报13.32港元，成交额2707.82万港元。尽管公司核心产品塞纳帕利近期获得欧洲药品管理局人用药品委员会积极意见，且该药已在国内纳入医保并实现快速放量，但股价在连续上涨后出现明显获利回吐压力。此前塞纳帕利国际化里程碑落地叠加港股通纳入，推动股价阶段性走强，部分资金选择在利好兑现后锁定收益。公司是一家处于商业化阶段的生物技术企业，核心产品塞纳帕利已在中国获批用于卵巢癌一线维持治疗，并持续推进欧洲等海外市场布局。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"塞纳帕利利好兑现，英派药业盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673025594","title":"英派藥業－Ｂ(07630)股價下跌8.075%，現價港幣$13.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2673025594","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673025594?lang=zh_tw&edition=fundamental","pubTime":"2026-10-08 14:00","pubTimestamp":1791439200,"startTime":"0","endTime":"0","summary":"[下跌股]英派药业－Ｂ(07630) 股价在下午02:00比前收市价下跌8.075%，现股价为港币$13.32。至目前为止，今日最高价为$14.76，而最低价为$13.32。总成交量为193.5万股，总成交金额为港币$2.667千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144019223_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144019223_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2610083182/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2610083182/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172946206","title":"英派藥業-B9月股份變動月報：股本維持不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1172946206","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172946206?lang=zh_tw&edition=fundamental","pubTime":"2026-10-05 16:39","pubTimestamp":1791189541,"startTime":"0","endTime":"0","summary":"南京英派药业股份有限公司于2026年10月5日发布2026年9月股份变动月报。报告显示，截至2026年9月30日，公司法定注册股本及已发行股份数目均无变化，股本总体保持稳定。公告披露，公司的法定/注册股本为人民币282,461,530元，每股面值1元，截至9月末法定/注册股份总数为282,461,530股。本月内，此类普通H股无新增发行、无减发、无库藏股变动及注销情况。本次公告由执行董事兼首席执行官蔡遂雄签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174475215","title":"異動解讀｜英派藥業-B盤中上漲8.26%，塞納帕利歐洲CHMP獲批利好持續發酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1174475215","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174475215?lang=zh_tw&edition=fundamental","pubTime":"2026-09-29 13:31","pubTimestamp":1790659912,"startTime":"0","endTime":"0","summary":"9月29日，英派药业-B盘中上涨8.26%，报14.03港元，成交额5400.01万港元，此前该股曾一度回调逾10%后企稳反弹。消息面上，公司核心产品塞纳帕利近期获欧洲药品管理局人用药品委员会积极意见，建议批准其用于晚期上皮性卵巢癌等维持治疗的上市许可，后续将提交欧盟委员会作出最终决定，一旦获批将可在所有欧盟成员国及欧洲经济区国家上市销售。此外，公司此前已与Pharmanovia达成独家授权协议，覆盖欧洲、中东、北非等地区，最高交易对价达4.235亿欧元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"塞纳帕利欧洲获批在望，英派药业上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671529388","title":"英派藥業－Ｂ(07630)股價上升5.093%，現價港幣$13.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2671529388","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671529388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-29 13:05","pubTimestamp":1790658300,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在下午01:05比前收市价上升5.093%，现股价为港币$13.62。至目前为止，今日最高价为$13.62，而最低价为$12.94。总成交量为285.28万股，总成交金额为港币$3.781千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609291502/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609291502/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122893246","title":"異動解讀｜英派藥業-B盤中下跌8.05%，前期大漲後回調疊加生物科技板塊整體走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1122893246","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122893246?lang=zh_tw&edition=fundamental","pubTime":"2026-09-24 10:12","pubTimestamp":1790215920,"startTime":"0","endTime":"0","summary":"9月24日，英派药业-B盘中下跌8.05%，报13.93港元，成交额3770.61万港元。该股此前因核心产品塞纳帕利获欧洲药品管理局（EMA）人用药品委员会（CHMP）积极意见，建议批准其用于晚期卵巢癌等维持治疗的上市许可，股价在9月21日单日大涨逾27%，盘中一度涨超40%至20.56港元，短期累计涨幅显著。经历快速拉升后，获利回吐压力加大。与此同时，生物科技板块整体承压，康方生物跌3.54%、荣昌生物跌5.71%、三生制药跌3.7%、信达生物跌3.53%，板块联动下行对个股形成拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"英派药业涨后回调，生物科技板块走弱拖累","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669310674","title":"英派藥業－Ｂ(07630)出現大手賣出70.72萬股，成交價$14.53，涉資1.028千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2669310674","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669310674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 16:01","pubTimestamp":1790150460,"startTime":"0","endTime":"0","summary":"[大手成交]英派药业－Ｂ(07630)在下午04:01出现大手卖出，成交量为70.72万，成交价为港币$14.53，涉资1.028千万。至目前为止，股价跌5.638%，今日最高价为$17.3，而最低价为$14.53，总成交量为1.067千万股，总成交金额港币$1.716亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609235285/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609235285/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669215608","title":"港股收盤(09.21) | 恒指漲1.18%重上兩萬五 創新藥概念股全線爆發 中生製藥(01177)領升藍籌","url":"https://stock-news.laohu8.com/highlight/detail?id=2669215608","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669215608?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 16:26","pubTimestamp":1789979213,"startTime":"0","endTime":"0","summary":"截至收盘，恒生指数涨1.18%或291.93点，报25042.71点，全日成交额2027.31亿港元；恒生国企指数涨1.39%，报8339.63点；恒生科技指数涨0.40%，报4423.29点。蓝筹股表现中国生物制药领涨蓝筹。创新药概念股全线爆发。截至收盘，康方生物涨9.72%，报99.3港元；三生制药涨9.33%，报17.220港元；中国生物制药涨8.23%，报5.920港元；石药集团涨7.56%，报9.605港元。截至收盘，跌17.58%，报20.06港元。安德利公告，拟以现金共计7.93亿元累计收购甬强科技62.06%的股权，从而取得对甬强科技的控制权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1555","82800","HHImain","01918","03115","02800","IBBQ","07300","HK0000165453.HKD","06978","BK1589","BK4588","03037","BK1515","MHImain","BK1574","BK4585","MCHmain","09115","SG9999014674.SGD","HSImain","BK1161","BK1166","07630","MEDX","02833","159992","IE00BZ08YS42.EUR","BK1240","01177","VXUS","BK1109","IE00BZ08YT58.USD","01138","07500","BK1535","IE00BZ08YR35.GBP","07200","03419","06727","83115","KCAI","BK1521","LNGR","BK1191","513600","HSI","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669340991","title":"英派藥業－Ｂ(07630)股價大幅上升47.352%，現價港幣$19.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2669340991","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669340991?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 11:48","pubTimestamp":1789962480,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在上午11:47比前收市价大幅上升47.352%，现股价为港币$19.2。至目前为止，今日最高价为$19.2，而最低价为$13.7。总成交量为2.275千万股，总成交金额为港币$3.874亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609212073/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609212073/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669349171","title":"英派藥業-B（07630）盤中拉升逾40% 藥品Sepalna上市許可獲歐洲CHMP建議批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2669349171","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669349171?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 11:33","pubTimestamp":1789961630,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英派药业-B 盘中逆市拉升40.06%，暂报18.25港元，成交额3.25亿港元。消息面上，该公司发布公告，欧洲药品管理局人用药品委员会已通过了一项积极意见，建议批准药品Sepalna的上市许可，该药旨在用于晚期上皮性卵巢癌、输卵管癌及原发性腹膜癌的维持治疗。于CHMP建议批准后，塞纳帕利将提交至欧盟委员会作出最终决定。一旦获得欧盟委员会批准，塞纳帕利将获准在所有欧盟成员国及欧洲经济区国家上市销售。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHMP","07630","IPOS","BK1161","BK4087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669131578","title":"港股異動 | 英派藥業-B(07630.HK)漲幅擴大逾41% 塞納帕利國際化里程碑落地 公司入通有望持續吸引南下資金","url":"https://stock-news.laohu8.com/highlight/detail?id=2669131578","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669131578?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 10:46","pubTimestamp":1789958791,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136901","title":"英派藥業-B盤初大漲逾22%，塞納帕利獲CHMP積極意見","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136901","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669136901?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 09:42","pubTimestamp":1789954959,"startTime":"0","endTime":"0","summary":"，英派药业-B发布公告，欧洲药品管理局（EMA）人用药品委员会（CHMP）已通过了一项积极意见，建议批准药品Sepalna®（塞纳帕利）的上市许可（MA），该药旨在用于晚期上皮性卵巢癌、输卵管癌及原发性腹膜癌的维持治疗。于CHMP建议批准后，塞纳帕利将提交至欧盟委员会（EC）作出最终决定。一旦获得欧盟委员会批准，塞纳帕利将获准在所有欧盟成员国及欧洲经济区国家上市销售。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-21/doc-inispynh5991178.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK4087","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669113660","title":"港股異動 | 英派藥業-B(07630.HK)高開逾7% 塞納帕利獲CHMP積極意見 近期與Pharmanovia達成獨家合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2669113660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669113660?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 09:29","pubTimestamp":1789954177,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669138239","title":"智通港股早知道 | 住建部指房地產進入存量時代 MiniMax(00100) Code CLI正式開源","url":"https://stock-news.laohu8.com/highlight/detail?id=2669138239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669138239?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 07:32","pubTimestamp":1789947156,"startTime":"0","endTime":"0","summary":"MiniMax Code CLI 正式开源18日晚，MiniMax Code CLI的v0.4.12版本面向全球开发者正式开放，并且以 MIT 协议正式开放源代码。MiniMax Code CLI是MiniMax Code客户端的核心组件。MiniMax表示，希望通过优秀的 harness 设计，持续释放模型能力，缩短任务等待时间。一旦获得欧盟委员会批准，塞纳帕利将获准在所有欧盟成员国及欧洲经济区国家上市销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00100","REET","07630","BK1148","BK1109","BK1161","06727","BK1117","BK1163","BK4585","BK4588","VXUS","08646","BK1105","09979","03223","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668292861","title":"重磅利好落地！塞納帕利獲歐洲藥品管理局批准 英派藥業-B (07630)收盤大漲15.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668292861","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668292861?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 19:24","pubTimestamp":1789730648,"startTime":"0","endTime":"0","summary":"智通财经获悉，9月18日，创新药企英派药业-B走出明显拉升行情，全天收报13.03 港元，较前一交易日上涨 1.75 港元，涨幅15.51%。于CHMP建议批准后，塞纳帕利将提交至欧盟委员会作出最终决定。一旦获得欧盟委员会批准，塞纳帕利将获准在所有欧盟成员国及欧洲经济区国家上市销售。市场分析认为，创新药板块情绪修复叠加塞纳帕利欧洲药品管理局获批这一国际化里程碑落地，叠加港股通纳入、国内产品放量等多重利好，带动资金积极布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"重磅利好落地！塞纳帕利获欧洲药品管理局批准 英派药业-B (07630)收盘大涨15.51%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668405459","title":"英派藥業-B(07630.HK)：塞納帕利獲CHMP積極意見 有望用於晚期上皮性卵巢癌、輸卵管癌及原發性腹膜癌的一線維持治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2668405459","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668405459?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:51","pubTimestamp":1789728715,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195688893","title":"英派藥業-B（07630）PARP抑制劑塞納帕利獲EMA CHMP積極意見 邁向歐盟上市關鍵一步","url":"https://stock-news.laohu8.com/highlight/detail?id=1195688893","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195688893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:51","pubTimestamp":1789728703,"startTime":"0","endTime":"0","summary":"2026年9月18日，英派药业-B发布自愿公告称，其自主研发的PARP1/2抑制剂塞纳帕利已获欧洲药品管理局人用药品委员会给出上市许可积极意见，用于晚期上皮性卵巢癌、输卵管癌及原发性腹膜癌患者的一线维持治疗。按照监管流程，相关申请将提交欧盟委员会作出最终决定；若获批准，塞纳帕利将可在全部欧盟成员国及欧洲经济区国家上市销售。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":123,"code":"91000000","status":"200"}]}}